Crypto
Second XRP ETF Filed with SEC – Is the big XRP Boom Coming Now?
Canary Capital’s filing for an XRP spot ETF would allow investors to gain exposure to XRP without directly handling cryptocurrencies, appealing especially to institutional investors. If approved, this ETF could boost XRP’s credibility and attract traditional investors. The SEC’s decision on this application could set a regulatory precedent for further XRP ETFs and broader crypto acceptance.
The world of cryptocurrencies is in motion again after the second provider submitted an application for an exchange-traded fund (ETF) on XRP. After an initial submission of a spot ETF for XRP, the investment firm Canary Capital has now also submitted an application to the US Securities and Exchange Commission (SEC). This development shows that interest in XRP as an investable asset continues to grow.
XRP and its meaning
XRP, Ripple Labs’ cryptocurrency, is particularly known for its efficiency in cross-border transactions. Despite ongoing regulatory battles with the SEC, XRP remains one of the largest and most well-known cryptocurrencies. A spot ETF on XRP could have the potential to make this digital currency even more accessible and open the market to institutional investors.
Why an XRP ETF is important
An ETF that holds XRP directly would allow investors to participate in the price increase of XRP without dealing with the technical challenges of directly acquiring and holding cryptocurrencies.
This is particularly attractive to institutional investors looking for a regulated and secure way to invest in cryptocurrencies. In addition, such an ETF could help further establish the crypto market and help it gain more credibility and acceptance among traditional investors.
Canary Capital’s application
Canary Capital is the second provider to file for a spot ETF on XRP with the SEC after an initial application. The ETF would track the actual price of XRP, making it an exciting opportunity for investors who want to bet on the price performance of this cryptocurrency.
The filing underscores the growing confidence of financial services providers in the crypto market, despite the challenges posed by regulatory uncertainty.
The regulatory hurdle
The SEC has been cautious in the past when it comes to approving crypto ETFs. While some ETFs on Bitcoin and Ethereum have already been approved, the agency has been hesitant towards less established cryptocurrencies such as XRP. The decision on Canary Capital’s application could set a precedent and pave the way for more XRP ETFs.
Conclusion
The filing of a second XRP ETF application by Canary Capital shows that interest in cryptocurrencies as a regulated form of investment continues to grow. If the SEC approves this ETF, it could not only affect the XRP price but also strengthen the acceptance of cryptocurrencies among institutional investors. The next few weeks will show how the authority responds to this second application.
__
(Featured image by Alesia Kozik via Pexels)
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in BLOCK-BUILDERS.DE. A third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us
-
Biotech1 week ago
Abbott Presents Innovative Solutions to IDIS to Improve the Treatment of Mitral and Tricuspid Regurgitation
-
Crowdfunding2 weeks ago
The Akka.app Platform, Authorized in France, Also Launches Its Investment Club in Italy
-
Crypto3 days ago
Thought XRP Was Hot? You Won’t Believe What’s About to Happen to RWA Tokenization Pioneer OXBR
-
Biotech1 week ago
Moderna Sees Revenue Plummet by 44% through September, But Cuts Losses